Home > List All Publishers > BioSeeker Group AB

BioSeeker Group AB

BioSeeker Group is a business and competitive intelligence company for investment, venture and R&D management of biotechnology and pharmaceutical companies. It serves the needs of individuals, companies, and institutional clients with a diverse range of information and analysis services.

BioSeeker Group has a strong client focus providing decision-makers, investors, and management people with candid, credible research coverage on biotechnology and pharmaceutical companies. The firm is committed to creating value for clients by providing wisdom and high quality services that meet clients' needs. BioSeeker Group clients and projects are kept confidential.

List of reports from BioSeeker Group AB

Oncology Drug Pipeline Update (Premium) 2/12/2013 \| published by: BioSeeker Group AB ... 120 indications in oncology via our intuitive guided searches, innovative filters, and the result presented in smart reports. Each drug profile is a synopsis of the history of the drug, from companies involved in the ... \| read more...	$5,175.00
Oncology Drug Pipeline Update (Premium) - Online 2/12/2013 \| published by: BioSeeker Group AB ... presented in smart, online reports available for download. Each drug profile is a synopsis of the history of the drug, from companies involved in the drug’s discovery and development, patent protection, target/ MoA, indications in ... \| read more...	$4,425.00
Analytical Tool - Cancer Immunotherapy 1/21/2013 \| published by: BioSeeker Group AB ... map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current treatment strategies ... \| read more...	$8,925.00
Oncology Drug Pathway Analyzer 1/14/2013 \| published by: BioSeeker Group AB ... many different types of cancer to a wide array of pathways. The included drugs are all from early stage development to market in maturity; also featuring ceased and suspended drugs. The Oncology Drug Pathway Analyzer ... \| read more...	$4,455.00
Triple Analysis: Pancreatic Cancer, Antibodies and Peptides 1/7/2013 \| published by: BioSeeker Group AB ... a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different ... \| read more...	$5,175.00
Triple Analysis: Prostate Cancer, Apoptosis and Peptides 1/7/2013 \| published by: BioSeeker Group AB ... to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area ... \| read more...	$5,175.00
Triple Analysis: Prostate Cancer, Angiogenesis and Peptides 1/7/2013 \| published by: BioSeeker Group AB ... to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area ... \| read more...	$5,175.00
Triple Analysis: Prostate Cancer, Protein Kinase Inhibitors and Peptides 1/7/2013 \| published by: BioSeeker Group AB ... evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer ... \| read more...	$5,175.00
Triple Analysis: Prostate Cancer, Antibodies and Peptides 1/7/2013 \| published by: BioSeeker Group AB ... a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different ... \| read more...	$5,175.00
Triple Analysis: Protein Kinase Inhibitors, Antibodies and Peptides 1/7/2013 \| published by: BioSeeker Group AB ... to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area ... \| read more...	$5,175.00
Triple Analysis: Breast Cancer, Colorectal Cancer and Peptides 1/7/2013 \| published by: BioSeeker Group AB ... in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between ... \| read more...	$5,175.00
Triple Analysis: Breast Cancer, Lymphoma and Peptides 1/7/2013 \| published by: BioSeeker Group AB ... a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different ... \| read more...	$5,175.00
Triple Analysis: Breast Cancer, Pancreatic Cancer and Peptides 1/7/2013 \| published by: BioSeeker Group AB ... in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between ... \| read more...	$5,175.00
Triple Analysis: Breast Cancer, Prostate Cancer and Peptides 1/7/2013 \| published by: BioSeeker Group AB ... in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between ... \| read more...	$5,175.00
Triple Analysis: Breast Cancer, Angiogenesis and Peptides 1/7/2013 \| published by: BioSeeker Group AB ... to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area ... \| read more...	$5,175.00
Triple Analysis: Breast Cancer, Protein Kinase Inhibitors and Peptides 1/7/2013 \| published by: BioSeeker Group AB ... evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer ... \| read more...	$5,175.00
Triple Analysis: Breast Cancer, Antibodies and Peptides 1/7/2013 \| published by: BioSeeker Group AB ... a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different ... \| read more...	$5,175.00
Triple Analysis: Apoptosis, Angiogenesis and Peptides 1/7/2013 \| published by: BioSeeker Group AB ... standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but ... \| read more...	$5,175.00
Triple Analysis: Angiogenesis, Protein Kinase Inhibitors and Peptides 1/7/2013 \| published by: BioSeeker Group AB ... according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus ... \| read more...	$5,175.00
Triple Analysis: Angiogenesis, Antibodies and Peptides 1/7/2013 \| published by: BioSeeker Group AB ... criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also ... \| read more...	$5,175.00
Cancer Peptides: From First-in-Class to Best-in-Class? 1/7/2013 \| published by: BioSeeker Group AB ... Which targets, tumor types and companies are setting the path? What is first-in-class in the cancer peptide pipeline? Is First-in-Class the Best-in-Class? Indication expansion opportunities Drug repositioning opportunities Which pathways are targeted, by what and ... \| read more...	$3,675.00
Triple Analysis: Colorectal Cancer, Leukemia and Peptides 1/7/2013 \| published by: BioSeeker Group AB ... a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different ... \| read more...	$5,175.00
Triple Analysis: Colorectal Cancer, Prostate Cancer and Peptides 1/7/2013 \| published by: BioSeeker Group AB ... in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between ... \| read more...	$5,175.00
Triple Analysis: Colorectal Cancer, Apoptosis and Peptides 1/7/2013 \| published by: BioSeeker Group AB ... to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area ... \| read more...	$5,175.00
Triple Analysis: Colorectal Cancer, Protein Kinase Inhibitors and Peptides 1/7/2013 \| published by: BioSeeker Group AB ... evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer ... \| read more...	$5,175.00

< prev 6 7 8 9 10 11 12 13 14 15 next >